Hologic Inc
1HOLX
Company Profile
Business description
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.
Contact
250 Campus Drive
MarlboroughMA01752
USAT: +1 508 263-2900
Sector
Healthcare
Stock type
Defensive
Industry
Medical Instruments & Supplies
Fiscal Year End
30 September 2025
Employees
7,063
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,777.90 | 50.80 | -0.58% |
CAC 40 | 7,878.46 | 111.75 | 1.44% |
DAX 40 | 24,549.56 | 342.65 | 1.42% |
Dow JONES (US) | 44,408.61 | 167.85 | 0.38% |
FTSE 100 | 8,867.02 | 12.84 | 0.15% |
HKSE | 23,892.32 | 255.75 | -1.06% |
NASDAQ | 20,566.76 | 148.30 | 0.73% |
Nikkei 225 | 39,821.28 | 132.47 | 0.33% |
NZX 50 Index | 12,768.61 | 90.41 | -0.70% |
S&P 500 | 6,251.69 | 26.17 | 0.42% |
S&P/ASX 200 | 8,538.60 | 52.10 | -0.61% |
SSE Composite Index | 3,493.05 | 4.43 | -0.13% |